Horizon Discovery sponsored this GEN and Rosalind Franklin Society "Women in Science" webinar.
Watch Jennifer Doudna in a candid “fireside chat” with several of her colleagues and friends to discuss the pivotal research that led to the award and celebrate a truly groundbreaking scientist. CRISPR pioneer Jennifer Doudna, PhD (University of California, Berkeley/HHMI) was recently awarded the 2020 Nobel Prize in Chemistry with Emmanuelle Charpentier, PhD, a microbiologist at the Max Planck Institute in Berlin. In 2012, the Doudna and Charpentier labs teamed up to publish a landmark paper in which they adapted the CRISPR microbial anti-viral defense system to create a programmable method for gene targeting. The work provided the foundation for CRISPR genome editing, which has become not only a ubiquitous research tool used around the world, but also applied in clinical gene therapy, diagnostics, agriculture, and many other applications. Doudna has embraced her leadership role, spearheading vital discussions about the ethics of hereditary genome editing, championing the value of basic academic research, and serving as an inspirational role model for women in science.